A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Authors
Keywords
Amyotrophic lateral sclerosis, Mouse models, Tracheotomy, Adverse events, Myalgia, Animal models, Inflammatory diseases, Quality of life
Journal
PLoS One
Volume 7, Issue 6, Pages e37885
Publisher
Public Library of Science (PLoS)
Online
2012-06-09
DOI
10.1371/journal.pone.0037885
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
- (2016) Aline Milane et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Differential Involvement of Optineurin in Amyotrophic Lateral Sclerosis With or Without SOD1 Mutations
- (2011) Han-Xiang Deng ARCHIVES OF NEUROLOGY
- Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
- (2011) Thomas Philips et al. LANCET NEUROLOGY
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
- (2011) Sabrina Paganoni et al. MUSCLE & NERVE
- The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
- (2011) Merit Cudkowicz et al. NATURE MEDICINE
- Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones
- (2011) Min Lu et al. NATURE MEDICINE
- A role for central nervous system PPAR-γ in the regulation of energy balance
- (2011) Karen K Ryan et al. NATURE MEDICINE
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis
- (2010) J. Dorst et al. JOURNAL OF NEUROLOGY
- Energy metabolism in amyotrophic lateral sclerosis
- (2010) Luc Dupuis et al. LANCET NEUROLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice
- (2009) Chiara Pizzasegola et al. Amyotrophic Lateral Sclerosis
- No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS
- (2009) Alan Gill et al. PLoS One
- Design, power, and interpretation of studies in the standard murine model of ALS
- (2008) Sean Scott et al. Amyotrophic Lateral Sclerosis
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
- (2008) L. Dupuis et al. NEUROLOGY
- Effects of the PPARγ activator pioglitazone on p38 MAP kinase and IκBα in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis
- (2008) Noriyuki Shibata et al. NEUROPATHOLOGY
- Lithium delays progression of amyotrophic lateral sclerosis
- (2008) F. Fornai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started